Clinical trial

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

NCT06676319

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusACTIVE_NOT_RECRUITING
Study typeINTERVENTIONAL
Start date2024-11-07
PhasePHASE2
Advertisement

Sponsors & collaborators

Sanofilead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.